Clinical Trial Update: Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 trial using hyperpolarized carbon-13 metabolic imaging to detect radiation-induced cardiotoxicity in thoracic cancers, including left-sided b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Thoracic Malignancies

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Thoracic Cancer, Left Sided Breast Cancer | EARLY_Phase 1 | Status: TERMINATED